IL17A and neoplasm: Thus, the inflammatory bladder microenvironment could contribute to the conversion of group 1 ILCs to Th17‐like phenotype, analogous to the conversion of traditional tumor‐protective ILC1 cells into IL‐17‐producing ILCs in lung cancer.47